Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson’s Disease

Phosphorylated α-synuclein in skin nerve fibres differentiates Parkinson’s disease from multiple system atrophy

(2015) Leonora Zange et al.   BRAIN

Peripheral synuclein tissue markers: a step closer to Parkinson’s disease diagnosis: Figure 1

(2015) Eduardo Tolosa et al.   BRAIN

Parkinson disease with REM sleep behavior disorder: Features,  -synuclein, and inflammation

(2015) Y. Hu et al.   NEUROLOGY

Colonic mucosal  -synuclein lacks specificity as a biomarker for Parkinson disease

(2015) N. P. Visanji et al.   NEUROLOGY

Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort

(2014) Tessandra Stewart et al.   AMERICAN JOURNAL OF PATHOLOGY

Detection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility study

(2014) Ursula Unterberger et al.   CLINICAL NEUROPATHOLOGY

Extracellular α-synuclein—a novel and crucial factor in Lewy body diseases

(2014) He-Jin Lee et al.   Nature Reviews Neurology

Skin nerve  -synuclein deposits: A biomarker for idiopathic Parkinson disease

(2014) V. Donadio et al.   NEUROLOGY

CSF biomarkers and clinical progression of Parkinson disease

(2014) S. Hall et al.   NEUROLOGY

Mind the gut: secretion of α-synuclein by enteric neurons

(2013) Stefan A. Grathwohl et al.   JOURNAL OF NEUROCHEMISTRY

Cerebrospinal fluid biomarkers in Parkinson disease

(2013) Lucilla Parnetti et al.   Nature Reviews Neurology

The Function of α-Synuclein

(2013) Jacob T. Bendor et al.   NEURON

Diagnostic value of minor salivary glands biopsy for the detection of Lewy pathology

(2013) Emmanuelle Folgoas et al.   NEUROSCIENCE LETTERS

EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease

(2012) A. Berardelli et al.   EUROPEAN JOURNAL OF NEUROLOGY

α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, andEscherichia coliExists Predominantly as Disordered Monomer

(2012) Bruno Fauvet et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease

(2012) Min Jeong Park et al.   Journal of Clinical Neurology

Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship

(2012) Maria Xilouri et al.   MOLECULAR NEUROBIOLOGY

Sensitivity and specificity of Addenbrooke’s Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson’s disease

(2012) B. Kaszás et al.   PARKINSONISM & RELATED DISORDERS

α-Synuclein misfolding and Parkinson's disease

(2011) Leonid Breydo et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Pathological roles of α-synuclein in neurological disorders

(2011) Kostas Vekrellis et al.   LANCET NEUROLOGY

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

(2011) Brit Mollenhauer et al.   LANCET NEUROLOGY

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias

(2011) Lucilla Parnetti et al.   MOVEMENT DISORDERS

Pathological correlates of gastrointestinal dysfunction in Parkinson's disease

(2011) Maria G. Cersosimo et al.   NEUROBIOLOGY OF DISEASE

In vivo demonstration that  -synuclein oligomers are toxic

(2011) B. Winner et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Characterization of the Non-Fibrillar α-Synuclein Oligomers

(2011) Dong-Pyo Hong et al.   PROTEIN AND PEPTIDE LETTERS

Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease

(2010) Kelly Del Tredici et al.   ACTA NEUROPATHOLOGICA

DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease

(2010) Zhen Hong et al.   BRAIN

Different sub-cellular localization of alpha-synuclein in the C57BL\6J mouse's central nervous system by two novel monoclonal antibodies

(2010) G. Vivacqua et al.   JOURNAL OF CHEMICAL NEUROANATOMY

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

Detection of elevated levels of  -synuclein oligomers in CSF from patients with Parkinson disease

(2010) T. Tokuda et al.   NEUROLOGY

Hyposialorrhea as an early manifestation of Parkinson disease

(2009) M.G. Cersósimo et al.   AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL

Detection of elevated levels of soluble  -synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies

(2009) K. E. Paleologou et al.   BRAIN

Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria

(2009) Dennis W Dickson et al.   LANCET NEUROLOGY

Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease

(2009) S. Hoops et al.   NEUROLOGY

Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: Autonomic pathway implicated in Parkinson's disease?

(2008) R.J. Phillips et al.   NEUROSCIENCE